Aliskiren add-on therapy effectively reduces proteinuria in chronic kidney disease: an open-label prospective trial. [electronic resource]
Producer: 20150520Description: 271-7 p. digitalISSN:- 1752-8976
- Amides -- adverse effects
- Antihypertensive Agents -- pharmacology
- Blood Pressure -- drug effects
- Creatinine -- blood
- Demography
- Female
- Fumarates -- adverse effects
- Glomerular Filtration Rate -- drug effects
- Humans
- Male
- Middle Aged
- Prospective Studies
- Proteinuria -- blood
- Renal Insufficiency, Chronic -- blood
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.